A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions

Pompe DiseaseMucopolysaccharidosis Type I (MPS I)

Trial Locations (1)

Investigational Site Italy, Italy